Organoids are one of the tools the FDA identified as a way to reduce animal testing in pre-clinical studies, but they do much more. Dr. Alexis Santana discusses Samsung Biologics’ organoid services: what they are and how they are used, their ability to grealty reduce time from discovery through commercialization, and how they will shape the future of drug devlopment.
The Catalent Story
The story of Catalent is one for the ages, an epic tale of growth and the establishment of what we now know as the modern pharmaceutical contract development and manufacturing organization. John Chiminski served as the CEO for fourteen extraordinary years and tells...
